For Doctors

Image

NeuroSynergy®360 is backed by 30+ independent medical journal publications for safety and efficacy.†


Placeholder


NeuroSynergy®360 is
Gluten-Free, Soy-Free, & Vegan.

This NutraTek™ – enhanced micronutrient formulation is backed by extensive clinical research. It is also GMO-free, sugar-free, gluten-free and vegan.

  • Connector.

    Highly Research-backed.

    The NeuroSynergy®360 formulation is backed by nearly 30 independent medical journal publications for safety and efficacy.†

  • Connector.

    Safe.

    Research and clinical outcomes show that NeuroSynergy®360 is formulated at safe levels for children and adults.†*

  • Connector.

    Comprehensive.

    The ultra bioavailable ingredients in NeuroSynergy®360 include 30+ essential nutrients at levels required to stabilize and optimize neurological function.*

  • Connector.

    Effective.

    Research shows that the NeuroSynergy®360 formulation is an effective micronutrient therapy for neurological stabilization and recovery.†*

  • Connector.

    Clinical.

    The clinical ingredients and specialized processing of NeuroSynergy®360 are unlike over-the-counter vitamin and mineral supplements, making it ideal for clinical use.*

  • Connector.

    Accessible.

    Available for clinicians and their patients at reduced pricing.

Clinical Supplementation

If you would like to offer NeuroSynergy®360 to patients, apply to become a preferred provider.

Becoming a Preferred Provider Allows You To:

  • Obtain special savings for patients.
  • Offer NeuroSynergy®360 without carrying stock.
  • Access patient resources.


Patients Prefer Research-Backed Treatments

Nearly thirty medical journal publications show the safety and efficacy of the NeuroSynergy®360 formulation. Providing patients with a balanced, optimized and bio-available broad-spectrum micronutrient can not only improve patient outcomes, but can also provide a solid foundation for preventative health.†*  

Become a NeuroSynergy®360 preferred provider today.

Become an Affiliate

Your preferred provider code will save your patients 15%.

Get Your Referral Code

Purchase Wholesale

Clinicians have access to special pricing.

Setup Wholesale Account

Why NeuroSynergy®360?

Dr. Popper at ISCN 2015: Micronutrients for a Metabolic Tune Up

To have a better understanding of why broad-spectrum clinical micronutrient therapy is recommended, watch this
truncated presentation by Dr. Charles Popper, Psychiatrist and Psychopharmacologist, Harvard, from the International Symposium of Clinical Neuroscience, 2015.
Contraindications and dosage are also covered.
For more detailed dosage information, download the Clinical Reference Guide below.

“After we’ve made a change in the nervous system…we like to use an evidence-based approach, that will facilitate and enhance all that [the patient] could possibly be.”Dr. Frederick R. Carrick, DC, PhD, MS-HPEd

Dr. Antonucci Discusses the Power of Effective Supplementation

Brain Injury: Micronutrient Formulation Greatly Improves Brain Function in Rats

Researchers at the world-renowned Canadian Centre for Behavioural Neuroscience conducted a series of controlled studies with rats fed a [predecessor version of NeuroSynergy®360] micronutrient blend* to test its effects on brain injuries and brain-related disorders.

Neuroscientists removed either the entire frontal lobe or part of the parietal lobe of the brain in treatment animals, and then the neural tissue was regrown with either the standard lab rat diet or with the treatment diet enhanced with the micronutrient formula. Brain recovery was significantly enhanced in the micronutrient-fed rats over those receiving the standard diet.

Impressively, on certain cognitive, behavioral, and motor tasks the micronutrient-fed treatment group scored as well as the control rats. Post-mortem analyses revealed that in both surgery and control animals the micronutrient treatment increased cortical thickness and dendritic length, supporting the use of micronutrient formulations for human brain trauma recovery in conjunction with brain rehabilitation therapies.

[Factors influencing frontal cortex development and recovery from early frontal injury. Halliwell C, Comeau W, Gibb R, Frost DO, Kolb B. Developmental Neurorehabilitation. 2009;12(5):269-78.]†

Research Summary

Nearly 30 independent medical journal publications back NeuroSynergy®360.†

Download Now

FAQs

All the answers your patients will need to know.

Download Now

Clinical Reference Guide

Interested in helping patients transition to micronutrients?
Here's what you need to know.

Download Now